Cyfuse Biomedical
3 known investors
Cyfuse Biomedical develops a platform technology that builds three-dimensional tissues and organs from spheroids using its proprietary Bio 3D Printer. Its products include the Bio 3D Printer, an in vitro liver-function evaluation tool for drug discovery support, and regenerative-medicine 3D cell products made entirely from cells.
BiotechHealthtechMedical Devices
Investors · 3
In the news
Frequently asked questions
- What does Cyfuse Biomedical do?
- Cyfuse Biomedical develops a platform technology that builds three-dimensional tissues and organs from spheroids using its proprietary Bio 3D Printer. Its products include the Bio 3D Printer, an in vitro liver-function evaluation tool for drug discovery support, and regenerative-medicine 3D cell products made entirely from cells.
- Who are Cyfuse Biomedical's investors?
- Cyfuse Biomedical's investors include DBJ Capital, Nippon Venture Capital, SMBC Venture Capital.